The Impact of COVID-19 on the <i>All of Us</i> Research Program
Sarra L. Hedden, James J. McClain, Allison Mandich, Rubin Baskir, Mark S Caulder, Joshua C. Denny, Michelle R J Hamlet, Irene Prabhu Das, Nicole McNeil Ford, Maria Lopez‐Class, Ahmed Elmi, Roshedah Wallace, Amantha Linkie, Holly A. Garriock
Abstract
The All of Us Research Program, a health and genetics epidemiologic data collection program, has been substantially affected by the coronavirus disease 2019 (COVID-19) pandemic. Although the program is highly digital in nature, certain aspects of the data collection require in-person interaction between staff and participants. Before the pandemic, the program was enrolling approximately 12,500 participants per month at more than 400 clinical sites. In March 2020, because of the pandemic, all in-person activity at program sites and by engagement partners was paused to develop processes and procedures for in-person activities that incorporated strict safety protocols. In addition, the program adopted new data collection methodologies to reduce the need for in-person activities. Through February 2022, a total of 224 clinical sites had reactivated in-person activity, and all enrollment and engagement partners have adopted new data collection methods that can be used remotely. As the COVID-19 pandemic persists, the program continues to require safety procedures for in-person activity and continues to generate and pilot methodologies that reduce risk and make it easier for participants to provide information.